Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Results are highly cyclical for NXCLF, so multiple-based fair value is less reliable here.
| FY | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | — | — | — | — | — | — | 10.60 | 11.56 | 10.54 | 8.01 | 6.86 | 5.50 | 3.27 | 1.86 | 1.74 | 1.25 | — | — |
| Low | — | — | — | — | — | — | 5.57 | 7.23 | 5.31 | 4.32 | 2.31 | 3.05 | 1.19 | 1.31 | 1.11 | 0.88 | — | — |
| Rev/Sh | 0.90 | 1.11 | 1.10 | 1.22 | 1.28 | 1.36 | 1.65 | 2.14 | 2.63 | 2.68 | 2.46 | 2.49 | 2.11 | 2.06 | 1.81 | -186.40 | 2.04E | 2.17E |
| Chg/Yr | — | +22% | -1% | +11% | +5% | +6% | +21% | +30% | +23% | +2% | -8% | +1% | -15% | -3% | -12% | -10393% | — | +6% |
| Div | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.04 | 0.05 | 0.03 | 0.02 | 0.03 | 0.01 | 0.07 | — | — |
Fair value (1.8x sales) multiplies each year's revenue per share by the price-to-sales ratio investors have typically paid for NXCLF — the median of the last 20 fiscal years' average price over that year's revenue per share. The line extends forward with analyst revenue estimates (dashed).
Revenue comes from reported quarters; share counts come from market value divided by the share price, so buybacks and splits are handled correctly. The verdict calls a stock over- or undervalued only when the price sits more than 10% from the line. Analyst estimates for this listing are published in its home currency; they are converted to the reported basis using the historical relationship between the two.